Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

L'Oreal FY11 Profit Rises - Quick Facts

L'Oreal SA (LRLCY.PK) Monday reported an increase in profit for the full-year 2011, as sales and gross margins improved.

Net profit excluding non-recurring items after non-controlling interests for the full-year 2011 improved to 2.58 billion euros or 4.32 euro per share from 2.37 billion euros or 4.01 euro per share last year.

Net profit after non-controlling interests for the period was 2.44 billion euros or 4.08 euro per share compared to 2.24 billion euros or 3.79 euro per share last year.

Sales for the full-year rose to 20.34 billion euros from 19.50 billion euros last year. On a like-for-like basis, sales for the year increased 5.1 percent from last year.

Full-year gross margin advanced 40 basis points to 71.2 percent.

Click here to receive FREE breaking news email alerts for L'Oreal Co. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
With disappointing earnings news generating some selling pressure, stocks have moved mostly lower in early trading on Friday. The major averages have slid firmly into negative territory after ending the previous session nearly flat. After reporting an unexpected drop in new orders for U.S. manufactured durable goods in the previous month, the Commerce Department released a report on Friday showing that durable goods orders rebounded by more than expected in the month of June. British economic growth remained high as expected in the second quarter as a robust expansion in the dominant service sector, and industry completely offset the slight weakness in the construction sector. With the second quarter expansion, GDP returned to its pre-crisis level. Gross domestic product grew 0.8 percent sequentially in the second quarter, the same rate as seen in the first quarter.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.